Biotech · Private company
Aimmune Therapeutics, Inc.
Track this companyFree. Adds Aimmune Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials111 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AR101Phase 3 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- AR101 powder provided in capsules & sachetsPhase 3 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- AR101 - Peanut protein capsulePhase 2 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- AR101 powder provided in capsulesPhase 2 · Peanut AllergyClinicalTrials.gov · fetched Nov 12, 2026
- AR201 powderPhase 2 · Hen Egg AllergyClinicalTrials.gov · fetched Nov 12, 2026
- Chia seedsStool Spore Colony Forming UnitsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Aimmune Longitudinal Collaboration StudyNA · ACTIVE_NOT_RECRUITING · started Jan 12, 2026ClinicalTrials.gov NCT07218640 · fetched Nov 12, 2026
- Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg AllergyPHASE2 · TERMINATED · started Aug 20, 2019ClinicalTrials.gov NCT04056299 · fetched Nov 12, 2026
- Peanut Oral Immunotherapy Study of Early Intervention for DesensitizationPHASE3 · COMPLETED · started Dec 27, 2018ClinicalTrials.gov NCT03736447 · fetched Nov 12, 2026
- Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)PHASE2 · COMPLETED · started Oct 3, 2018ClinicalTrials.gov NCT03682770 · fetched Nov 12, 2026
- Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)PHASE3 · COMPLETED · started Nov 2, 2017ClinicalTrials.gov NCT03292484 · fetched Nov 12, 2026
- AR101 Real-World Open-Label Extension StudyPHASE3 · COMPLETED · started Oct 18, 2017ClinicalTrials.gov NCT03337542 · fetched Nov 12, 2026
- Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES)PHASE3 · COMPLETED · started May 8, 2017ClinicalTrials.gov NCT03126227 · fetched Nov 12, 2026
- PALISADE Follow-on Study (ARC004)PHASE3 · COMPLETED · started Dec 29, 2016ClinicalTrials.gov NCT02993107 · fetched Nov 12, 2026
- Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)PHASE3 · COMPLETED · started Dec 22, 2015ClinicalTrials.gov NCT02635776 · fetched Nov 12, 2026
- Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On StudyPHASE2 · COMPLETED · started Aug 27, 2014ClinicalTrials.gov NCT02198664 · fetched Nov 12, 2026
- Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OITPHASE2 · COMPLETED · started Feb 6, 2014ClinicalTrials.gov NCT01987817 · fetched Nov 12, 2026